Thomas Ulas

ORCID: 0000-0002-9785-4197
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immune cells in cancer
  • COVID-19 Clinical Research Studies
  • Single-cell and spatial transcriptomics
  • Immune Cell Function and Interaction
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Immune Response and Inflammation
  • Gut microbiota and health
  • Neonatal Respiratory Health Research
  • Diet and metabolism studies
  • Bioinformatics and Genomic Networks
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Epigenetics and DNA Methylation
  • Blood disorders and treatments
  • Immunotherapy and Immune Responses
  • Digestive system and related health
  • Gene expression and cancer classification
  • T-cell and B-cell Immunology
  • Immune responses and vaccinations
  • RNA Research and Splicing
  • Cancer Genomics and Diagnostics
  • RNA modifications and cancer
  • Cancer-related molecular mechanisms research
  • Long-Term Effects of COVID-19
  • Inflammasome and immune disorders
  • Sepsis Diagnosis and Treatment

German Center for Neurodegenerative Diseases
2018-2025

University of Bonn
2016-2025

Epigenomics (Germany)
2019-2025

Life & Brain (Germany)
2015-2021

Technische Universität Braunschweig
2012-2021

Genomics (United Kingdom)
2021

Charité - Universitätsmedizin Berlin
2021

Highlights•Macrophages react with specific transcriptional programming upon distinct signals•Activation by TNF, PGE2, and P3C activates a STAT4-associated program•NFKB1, JUNB, CREB1 are central transcription factors of macrophage activation•Inflammatory signatures lost in alveolar macrophages from COPD patientsSummaryMacrophage activation is associated profound reprogramming. Although much progress has been made the understanding activation, polarization, function, programs regulating these...

10.1016/j.immuni.2014.01.006 article EN cc-by Immunity 2014-02-01
Jonas Schulte-Schrepping Nico Reusch Daniela Paclik Kevin Baßler Stephan Schlickeiser and 95 more Bowen Zhang Benjamin Krämer Tobias Krammer Sophia Brumhard Lorenzo Bonaguro Elena De Domenico Daniel Wendisch Martin Graßhoff Theodore S. Kapellos Michael Beckstette Tal Pecht Adem Saglam Oliver Dietrich Henrik E. Mei Axel Schulz Claudia Conrad Désirée Kunkel Ehsan Vafadarnejad Cheng‐Jian Xu Arik Horne Miriam Herbert Anna Drews Charlotte Thibeault Moritz Pfeiffer Stefan Hippenstiel Andreas C. Hocke Holger Müller-Redetzky Kathrin Heim Felix Machleidt Alexander Uhrig Laure Bosquillon de Jarcy Linda Jürgens Miriam Stegemann Christoph R. Glösenkamp Hans‐Dieter Volk Christine Goffinet Markus Landthaler Emanuel Wyler Philipp Georg Maria Schneider Chantip Dang‐Heine Nick Neuwinger Kai Kappert R Tauber Victor M. Corman Jan Raabe Kim M Kaiser M To Vinh Gereon Rieke Christian Meisel Thomas Ulas Matthias Becker Robert Geffers Martin Witzenrath Christian Drosten Norbert Suttorp Christof von Kalle Florian Kurth Kristian Händler Joachim L. Schultze Anna C. Aschenbrenner Yang Li Jacob Nattermann Birgit Sawitzki Antoine‐Emmanuel Saliba Leif Erik Sander Angel Angelov Robert Bals Alexander Bartholomäus Anke Becker Daniela Bezdan Ezio Bonifacio Peer Bork Thomas Clavel Maria Colomé‐Tatché Andreas Diefenbach Alexander Dilthey Nicole Fischer Konrad U. Förstner Julia-Stefanie Frick Julien Gagneur Alexander Goesmann Torsten Hain Michael Hummel Stefan Janssen Jörn Kalinowski René Kallies Birte Kehr Andreas Keller Sarah Kim-Hellmuth Christoph Klein Oliver Kohlbacher Jan O. Korbel Ingo Kurth Markus Landthaler

10.1016/j.cell.2020.08.001 article EN publisher-specific-oa Cell 2020-08-05

Microglia are embryonically seeded macrophages that contribute to brain development, homeostasis, and pathologies. It is thus essential decipher how microglial properties temporally regulated by intrinsic extrinsic factors, such as sexual identity the microbiome. Here, we found microglia undergo differentiation phases, discernable transcriptomic signatures chromatin accessibility landscapes, which can diverge in adult males females. Remarkably, absence of microbiome germ-free mice had a time...

10.1016/j.cell.2017.11.042 article EN cc-by Cell 2017-12-21
Stefanie Warnat‐Herresthal Hartmut Schultze Krishnaprasad Lingadahalli Shastry Sathyanarayanan Manamohan Saikat Mukherjee and 95 more Vishesh Garg Ravi Sarveswara Kristian Händler Peter Pickkers N. Ahmad Aziz Sofia Ira Ktena Florian Tran Michael Bitzer Stephan Ossowski Nicolas Casadei Christian Herr Daniel Petersheim Uta Behrends Fabian Kern Tobias Fehlmann Philipp Schommers Clara Lehmann Max Augustin Jan Rybniker Janine Altmüller Neha Mishra Joana P. Bernardes Benjamin Krämer Lorenzo Bonaguro Jonas Schulte-Schrepping Elena De Domenico Christian Siever Michael Kraut Milind Y. Desai Bruno Monnet Maria Saridaki Charles Siegel Anna Drews Melanie Nuesch-Germano Heidi Theis Jan Heyckendorf Stefan Schreiber Sarah Kim-Hellmuth Paul Balfanz Thomas Eggermann Peter Boor Ralf Hausmann Hannah Kuhn Susanne Isfort Julia C. Stingl Günther Schmalzing Christiane Kühl Rainer Röhrig Gernot Marx Stefan Uhlig Edgar Dahl Dirk Müller‐Wieland Michael Dreher Nikolaus Marx Jacob Nattermann Dirk Skowasch Ingo Kurth Andreas Keller Robert Bals Peter Nürnberg Olaf Rieß Philip Rosenstiel Mihai G. Netea Fabian J. Theis Sach Mukherjee Michael Backes Anna C. Aschenbrenner Thomas Ulas Angel Angelov Alexander Bartholomäus Anke Becker Daniela Bezdan Conny Blumert Ezio Bonifacio Peer Bork Boyke Bunk Helmut Blum Thomas Clavel Maria Colomé‐Tatché Markus Cornberg Inti Alberto De La Rosa Velázquez Andreas Diefenbach Alexander Dilthey Nicole Fischer Konrad U. Förstner Sören Franzenburg Julia-Stefanie Frick Gisela Gabernet Julien Gagneur Tina Ganzenmueller Marie Gauder Janina Geißert Alexander Goesmann Siri Göpel Adam Grundhoff

Fast and reliable detection of patients with severe heterogeneous illnesses is a major goal precision medicine1,2. Patients leukaemia can be identified using machine learning on the basis their blood transcriptomes3. However, there an increasing divide between what technically possible allowed, because privacy legislation4,5. Here, to facilitate integration any medical data from owner worldwide without violating laws, we introduce Swarm Learning-a decentralized machine-learning approach that...

10.1038/s41586-021-03583-3 article EN cc-by Nature 2021-05-26

How dying tumor cells get noticed Besides killing directly, some chemotherapies, such as anthracyclines, also activate the immune system to kill tumors. Vacchelli et al. discovered that in mice, anthracycline-induced antitumor immunity requires express protein formyl peptide receptor 1 (FPR1). Dendritic (DCs) near tumors expressed especially high amounts of FPR1. DCs normally capture fragments and use them nearby T tumors, but lacking FPR1 failed do this effectively. Individuals with breast...

10.1126/science.aad0779 article EN Science 2015-10-30
Joana P. Bernardes Neha Mishra Florian Tran Thomas Bahmer Lena Best and 95 more Johanna I. Blase Dora Bordoni Jeanette Franzenburg Ulf Geisen Jonathan Josephs‐Spaulding Philipp Köhler Axel Künstner Elisa Rosati Anna C. Aschenbrenner Petra Bächer Nathan Baran Teide Jens Boysen Burkhard Brandt Niklas Bruse Jonathan Dörr Andreas Dräger Gunnar Elke David Ellinghaus Julia Fischer Michael Förster André Franke Sören Franzenburg Norbert Frey Anette Friedrichs Janina Fuß Andreas Glück Jacob Hamm Finn Hinrichsen Marc P. Hoeppner Simon Imm Ralf Junker Sina Kaiser Ying H. Kan Rainer Knoll Christoph Lange Georg Laue Clemens Lier Matthias Lindner Γεώργιος Μαρίνος Robert Markewitz Jacob Nattermann Rainer Noth Peter Pickkers Klaus F. Rabe Alina Renz Christoph Röcken Jan Rupp Annika Schaffarzyk Alexander Scheffold Jonas Schulte-Schrepping Domagoj Schunk Dirk Skowasch Thomas Ulas Klaus‐Peter Wandinger Michael Wittig Johannes Zimmermann Hauke Busch Bimba F. Hoyer Christoph Kaleta Jan Heyckendorf Matthijs Kox Jan Rybniker Stefan Schreiber Joachim L. Schultze Philip Rosenstiel Nicholas E. Banovich Tushar J. Desai Oliver Eickelberg Muzlifa Haniffa Péter Horváth Jonathan A. Kropski Robert Lafyatis Joakim Lundeberg Kerstin B. Meyer Martijn C. Nawijn Marko Nikolić José Ordovas Montañes Dana Pe’er Purushothama Rao Tata Emma L. Rawlins Aviv Regev Paul A. Reyfman Christos Samakovlis Joachim L. Schultze Alex K. Shalek Douglas P. Shepherd Jason R. Spence Sarah A. Teichmann Fabian J. Theis Alexander M. Tsankov Maarten van den Berge Michael von Papen Jeffrey A. Whitsett Laure‐Emmanuelle Zaragosi Angel Angelov

10.1016/j.immuni.2020.11.017 article EN publisher-specific-oa Immunity 2020-11-26

Here we report the transcriptional profile of human microglia, isolated from normal-appearing grey matter (GM) and white (WM) multiple sclerosis (MS) non-neurological control donors, to find possible early changes related MS pathology. Microglia show a clear region-specific profile, indicated by higher expression type-I interferon genes in GM NF-κB pathway WM. Transcriptional microglia also differ between WM increased lipid metabolism gene expression, which relates pathology since active...

10.1038/s41467-019-08976-7 article EN cc-by Nature Communications 2019-03-13

Abstract Background The SARS-CoV-2 pandemic is currently leading to increasing numbers of COVID-19 patients all over the world. Clinical presentations range from asymptomatic, mild respiratory tract infection, severe cases with acute distress syndrome, failure, and death. Reports on a dysregulated immune system in call for better characterization understanding changes system. Methods In order dissect COVID-19-driven host responses, we performed RNA-seq whole blood cell transcriptomes...

10.1186/s13073-020-00823-5 article EN cc-by Genome Medicine 2021-01-13

Wound healing is a coordinated process that initially relies on pro-inflammatory macrophages, followed by pro-resolution function of these cells. Changes in cellular metabolism likely dictate distinct activities, but the nature changes has been unclear. Here, we profiled early- versus late-stage skin wound macrophages mice at both transcriptional and functional levels. We found glycolytic early phase not sufficient to ensure productive repair. Instead, combining conditional disruption...

10.1016/j.cmet.2021.10.004 article EN cc-by Cell Metabolism 2021-10-28

Human in vitro generated monocyte-derived dendritic cells (moDCs) and macrophages are used clinically, e.g., to induce immunity against cancer. However, their physiological counterparts, ontogeny, transcriptional regulation, heterogeneity remains largely unknown, hampering clinical use. High-dimensional techniques were elucidate transcriptional, phenotypic, functional differences between human vivo mononuclear phagocytes facilitate full potential the clinic. We demonstrate that monocytes...

10.1016/j.immuni.2017.11.024 article EN cc-by Immunity 2017-12-01

In mice, conventional and plasmacytoid dendritic cells (DCs) derive from separate hematopoietic precursors before they migrate to peripheral tissues. Moreover, two classes of DCs (cDC1 cDC2 DCs) one class (pDCs) have been shown be transcriptionally functionally distinct entities. humans, these three DC subtypes can identified using the cell surface markers CD1c (cDC2), CD141 (cDC1), CD303 (pDCs), albeit it remains elusive whether functionality is mainly determined by ontogeny or tissue...

10.1126/sciimmunol.aai7677 article EN Science Immunology 2016-12-17

Abstract Background The interplay of epigenetic processes and the intestinal microbiota may play an important role in development homeostasis. Previous studies have established that regulates a large proportion epithelial transcriptome adult host, but microbial effects on DNA methylation gene expression during early postnatal are still poorly understood. Here, we sought to investigate cells (IECs) development. Methods We collected IECs from small intestine each five 1-, 4- 12 16-week-old...

10.1186/s13073-018-0534-5 article EN cc-by Genome Medicine 2018-04-13
Coming Soon ...